Danaher Co. (NYSE:DHR) Shares Purchased by Global Trust Asset Management LLC

Global Trust Asset Management LLC increased its position in shares of Danaher Co. (NYSE:DHR) by 42.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,242 shares of the conglomerate’s stock after acquiring an additional 373 shares during the period. Global Trust Asset Management LLC’s holdings in Danaher were worth $255,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Danaher by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock worth $13,715,641,000 after acquiring an additional 315,912 shares in the last quarter. Geode Capital Management LLC lifted its stake in Danaher by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate’s stock worth $3,056,996,000 after acquiring an additional 315,446 shares in the last quarter. Norges Bank acquired a new position in Danaher during the 4th quarter worth about $2,130,740,000. Bank of New York Mellon Corp lifted its stake in Danaher by 5.4% during the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock worth $1,971,609,000 after acquiring an additional 441,012 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in Danaher by 14.3% during the 4th quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate’s stock worth $1,821,477,000 after purchasing an additional 992,594 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.2%

Danaher stock opened at $201.14 on Tuesday. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The stock has a 50 day moving average of $193.35 and a two-hundred day moving average of $210.53. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $143.95 billion, a price-to-earnings ratio of 38.09, a PEG ratio of 2.66 and a beta of 0.77.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The company had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. As a group, research analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.64%. Danaher’s payout ratio is 24.85%.

Analysts Set New Price Targets

DHR has been the topic of several recent research reports. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a report on Friday, March 14th. Guggenheim restated a “buy” rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Robert W. Baird cut their price target on Danaher from $231.00 to $225.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a report on Monday, June 9th. Finally, JPMorgan Chase & Co. cut their price target on Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a report on Tuesday, April 22nd. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $248.17.

Insiders Place Their Bets

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman now directly owns 3,105,808 shares of the company’s stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the firm’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares of the company’s stock, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.